Migraine polygenic risk score associates with efficacy of migraine-specific drugs.
Lisette J A KogelmanAnn-Louise EsserlindAnne Francke ChristensenSwapnil AwasthiStephan RipkeAndres IngasonOlafur B DavidssonChristian ErikstrupHenrik HjalgrimHenrik UllumJes OlesenThomas Folkmann Hansennull nullPublished in: Neurology. Genetics (2019)
The migraine PRS can significantly identify subgroups of patients with a higher-than-average likelihood of a positive response to triptans, which provides a first step toward genetics-based precision medicine in migraine.
Keyphrases